Key details
Sponsor
Synermore Biologics (Suzhou) Co., Ltd.
Collaborators
Peking University First Hospital, Shenzhen Second People's Hospital
Enrollment target
~232 participants
Primary completion
January 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
0 Years – 17 Years
Last updated January 2026